Work

Weekly carboplatin plus neoadjuvant anthracycline-taxane-based regimen in early triple-negative breast cancer: a prospective phase II trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO)

Year: 2019

Type: article

Study design: Clinical Trial

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-019-05259-z

Authors: Christel Fontaine, Vincent Renard, Heidi Van den Bulk, Peter Vuylsteke, Philip Glorieux, Catherine Dopchie, Lore Decoster, Leen Vanacker, Evandro de Azambuja, Jacques De Greve, Ahmad Awada, Hans Wildiers

Institutions: Universitair Ziekenhuis Brussel, AZ Sint-Lucas, Imelda Hospital, Centre Hospitalier de Wallonie Picarde, Université Libre de Bruxelles, Institut Jules Bordet, Universitair Ziekenhuis Leuven

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Amgen, Teva Pharmaceutical Industries, Amgen Nederland

OpenAlex ID: W2944313249

FWCI: 0.677

Cites: 26

Cited by: 14

Related to: 10